Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 30 INDUSTRY 4 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 4 Lymphoma, Mantle-Cell 3 Lymphoma, Follicular 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Multiple Myeloma 1 Leukemia 1 Hodgkin Disease 1

Interventions

Dexamethasone 45 Bortezomib 21 Lenalidomide 19 Cyclophosphamide 19 daratumumab 16 Calcium Dobesilate 13 Thalidomide 12 Melphalan 11 carfilzomib 9 Prednisone 7 pomalidomide 6 Peripheral Blood Stem Cell Transplantation 6 Doxorubicin 6 Filgrastim 5 dexamethasone acetate 4 dexamethasone 21-phosphate 4 auricularum 4 Vincristine 4 isatuximab 3 Interferon-alpha 3 Etoposide 3 selinexor 2 sargramostim 2 ixazomib 2 elotuzumab 2 cobimetinib 2 Steroids 2 Radiotherapy 2 Microarray Analysis 2 Granulocyte Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Multiple Myeloma × Bendamustine Hydrochloride × Clear all

NCT01045681 2020-12-07

BVD

Intergroupe Francophone du Myelome

Phase 2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡